Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• The intestinal barrier is a multilayered defense system crucial for preventing systemic circulation of luminal contents.
• It comprises physical components (epithelial cells, mucin layers) and functional elements (intestinal alkaline phosphatase, antibacterial proteins).
• Dysfunction of the intestinal barrier, marked by increased circulating lipopolysaccharide (LPS), is linked to various diseases.

Purpose of the Study:

• To review the current understanding of the intestinal barrier's composition, assessment, and modulation.
• To explore mechanisms of disease development due to intestinal barrier dysfunction.
• To identify potential therapeutic strategies for improving intestinal barrier function.

Main Methods:

• Literature review of existing research on intestinal barrier structure and function.
• Analysis of mechanisms linking barrier dysfunction to disease pathogenesis.
• Synthesis of information on methods for assessing and modulating intestinal barrier layers.

Main Results:

• Intestinal alkaline phosphatase (IAP) detoxifies lipopolysaccharide (LPS) by dephosphorylating its active Lipid A component, mitigating inflammation and translocation.
• Antibacterial proteins contribute to host defense against gut microbes.
• Changes in intestinal barrier layers are associated with disease development, highlighting the need for targeted interventions.

Conclusions:

• A comprehensive understanding of the intestinal barrier is essential for developing targeted therapies for barrier dysfunction-associated diseases.
• Modulating individual layers of the intestinal barrier holds therapeutic potential.
• Further research into assessment and therapeutic strategies for intestinal barrier dysfunction is warranted.